Clinical Trials Browser

Terminated × Carcinoma, Renal Cell × lenvatinib × Clear all

NCT06114940 2026-03-05

PLUTO

Phase 2 Terminated

Carcinoma, Renal Cell

NCT04955743 2025-11-24

Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma

Phase 2 Terminated

CNSDermatologicGenitourinary

Brain Neoplasms, Carcinoma, Renal Cell, Melanoma